MedTrace Logo

The Effectiveness of Peripheral Magnetic Stimulation in Men With Lower Urinary Tract Symptoms

NCT04807569 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2021-03-19

No results posted yet for this study

Summary

The main hypothesis of this study is that peripheral magnetic neuromodulation can correct the symptoms of lower urinary tract in men. We assume that under the influence of t peripheral magnetic stimulation, both the subjective state of patients assessed by standardized questionnaires and a urination diary, as well as the objective parameters, assessed by non-invasive urodynamic studies, will be improved. This study will use standard protocols built into the BTL Emsella magnetic stimulator.

Conditions

  • Bladder Hypersensitivity

Interventions

OTHER

Peripheral magnetic neuromodulation

Non-invasive peripheral magnetic neuromodulation using the BTL Emsella magnetic stimulator according to the manufacturer's standard protocol: "pelvic floor rehabilitation

DRUG

Taking drug Tamsulosin

Tamsulosin at a dose of 0.4 mg x 1 time per day orally for 1 month.

Sponsors & Collaborators

  • Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04807569 on ClinicalTrials.gov